Clinical trial
A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of…
NCT00347932 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00347932 |
|---|---|
| Title | A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis. |
| Official title | A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vehicle in the Treatment of Bacterial Conjunctivitis. |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Bacterial Conjunctivitis |
| Intervention type | Drug |
| Interventions | ISV-403, Vehicle |
| Enrollment | 957 |
| Start date | Jun 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jul 4, 2006 |
| Last update posted | Mar 24, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: